Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Crohn's disease.

Fergus Shanahan1

  • 1Department of Medicine, Clinical Sciences Building, Cork University Hospital, Cork, Ireland. F.shanahan@ucc.ie

Lancet (London, England)
|January 26, 2002
PubMed
Summary
This summary is machine-generated.

Crohn's disease involves T lymphocytes and genetic susceptibility, leading to immune dysregulation against gut bacteria. Understanding immune responses offers new therapeutic strategies for this complex inflammatory bowel disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut microbiome features associated with Bifidobacterium colonization predict personalized probiotic persistence patterns.

Nature communications·2026
Same author

Exploring the concept of bacterial memory.

Nature microbiology·2025
Same author

Toward a health-associated core keystone index for the human gut microbiome.

Cell reports·2025
Same author

Temporal stability and lack of variance in microbiome composition and functionality in fit recreational athletes.

Scientific reports·2025
Same author

Host-microbe multi-omics and succinotype profiling have prognostic value for future relapse in patients with inflammatory bowel disease.

Gut microbes·2025
Same author

International consensus statement on microbiome testing in clinical practice.

The lancet. Gastroenterology & hepatology·2024
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Immunology
  • Gastroenterology
  • Genetics

Background:

  • Crohn's disease is an immune-mediated disorder.
  • It affects genetically susceptible individuals.
  • Immune responses to enteric bacteria are dysregulated.

Purpose of the Study:

  • To improve understanding of Crohn's disease pathophysiology.
  • To explore new therapeutic options.
  • To investigate the role of immune regulation.

Main Methods:

  • Analysis of T lymphocyte-mediated immune responses.
  • Study of mucosal immune regulation.
  • Investigation of host-enteric bacteria interactions.

Main Results:

Related Experiment Videos

  • Breakdown in regulatory constraints on mucosal immunity observed.
  • Disease heterogeneity suggested with various underlying defects.
  • Conventional treatments focus on host response modification.

    • Conclusions:

    • Understanding immune reactivity enhances knowledge of Crohn's disease.
    • Therapeutic manipulation of enteric flora is a viable option.
    • Further research into disease heterogeneity is warranted.